C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/575 (2006.01)
Patent
CA 2567635
The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
La présente invention concerne des peptides activant sélectivement le récepteur VPAC2 et utiles dans le traitement du diabète.
Alsina-Fernandez Jorge
Bokvist Bengt Krister
Cummins Robert Chadwick
Glaesner Wolfgang
Gromada Jesper Lindgren
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Selective vpac2 receptor peptide agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective vpac2 receptor peptide agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective vpac2 receptor peptide agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1910303